Antifungal Activity of Disalt of Epipyrone A from

Alex J Lee, Joseph Hammond, Jeffrey Sheridan, Simon Swift, Andrew B Munkacsi, Silas G Villas-Boas

Abstract read

In one paragraph

Article in Journal of fungi (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it

0cells of the map it votes in

1citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

Discovery of novel repurposed anthelminthics againstCurrent research in parasitology & vector-borne diseases · 2026
Article

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Alex J LeeSchool of Biological Sciences, University of Auckland, Auckland 1010, New Zealand.

Joseph HammondSchool of Biological Sciences, Victoria University of Wellington, P.O. Box 600, Wellington 6140, New Zealand.

Jeffrey SheridanSchool of Biological Sciences, Victoria University of Wellington, P.O. Box 600, Wellington 6140, New Zealand.ORCID 0009-0006-8486-7737

Simon SwiftFaculty of Medical and Health Sciences, University of Auckland, Auckland 1023, New Zealand.ORCID 0000-0001-7352-1112

Andrew B MunkacsiSchool of Biological Sciences, Victoria University of Wellington, P.O. Box 600, Wellington 6140, New Zealand.

Silas G Villas-BoasSchool of Biological Sciences, University of Auckland, Auckland 1010, New Zealand.ORCID 0000-0003-0148-5882

Funding

New Zealand Ministry of Business, Innovation and Employment (MBIE) UOAX1410

6 · The paper itself

Abstract

Multidrug-resistant fungal pathogens and antifungal drug toxicity have challenged our current ability to fight fungal infections. Therefore, there is a strong global demand for novel antifungal molecules with the distinct mode of action and specificity to service the medical and agricultural sectors. Polyenes are a class of antifungal drugs with the broadest spectrum of activity among the current antifungal drugs. Epipyrone A, a water-soluble antifungal molecule with a unique, linear polyene structure, was isolated from the fungus

Indexed as

elo2fungicidemechanism of actionmetabolomicspolyeneSaccharomyces cerevisiaesphingolipid

Identifiers

PMID39330357

DOI10.3390/jof10090597

PMCPMC11433475

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.